JS
Joseph Stringer Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
49
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
89.2%
Neutral
10.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $103 |
39%
upside
| 8 | +15% |
0
%
| 26 Feb ‘26 9 days ago |
|
|
|
Buy
Maintained
| $139 |
49%
upside
| 9 | +8.8% |
0
%
| 26 Feb ‘26 9 days ago |
|
|
|
Buy
Maintained
| $18 |
88%
upside
| 4 | +20% |
0
%
| 24 Feb ‘26 11 days ago |
|
|
|
Buy
Reiterated
| $170 |
18%
upside
| 7 | +5.2% |
0
%
| 23 Feb ‘26 12 days ago |
|
|
|
Buy
Maintained
| $510 |
59%
upside
| 6 | +5.9% |
0
%
| 12 Feb ‘26 23 days ago |
|
|
|
Buy
Maintained
| $28 |
40%
upside
| 2 | +3.9% |
0
%
| 13 Jan ‘26 1 month ago |
|
|
|
Hold
Downgraded
| – | – | 8 | +40% |
0
%
| 14 Nov ‘25 3 months ago |
|
|
|
Hold
Downgraded
| $65 | – | 4 | +25% |
0
%
| 27 Oct ‘25 4 months ago |
|
|
|
Hold
Reiterated
| – | – | 1 | – |
–
| 20 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $35 |
1%
downside
| 4 | +60% |
0
%
| 10 Oct ‘25 4 months ago |
|
|
|
Buy
Maintained
| $28 |
162%
upside
| 4 | +30% |
0
%
| 6 Jun ‘25 9 months ago |
|
|
|
Hold
Downgraded
| $12 |
200%
upside
| 4 | +12% |
0
%
| 16 May ‘25 9 months ago |
|
|
|
Buy
Maintained
| $11 |
113%
upside
| 1 | +192% |
0
%
| 13 May ‘25 9 months ago |
|
|
|
Hold
Reiterated
| – | – | 1 | – |
–
| 6 May ‘25 10 months ago |
|
|
|
Buy
Reiterated
| $90 |
52%
upside
| 2 | +34% |
0
%
| 8 Apr ‘25 11 months ago |
|